Description

4-(2-Methyl-Imidazo[1,2-A]Pyrimidin-3-Yl)-Thiazol-2-Ylamine is a high-purity, advanced pharmaceutical intermediate characterized by its fused heterocyclic structure. This compound is of significant commercial importance for its role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily needed by research institutions and pharmaceutical manufacturers engaged in the development of new therapeutic agents, particularly within oncology and antiviral research domains.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the multi-step synthesis of complex drug candidates targeting specific biological pathways.
• Oncology Research: Used in the development of small molecule inhibitors and targeted therapies for various cancer types.
• Antiviral Drug Development: Employed as a scaffold in the research and synthesis of compounds with potential antiviral activity.
• Chemical Biology: Acts as a probe or ligand in biochemical assays to study protein interactions and enzyme functions.
• Agrochemical Research: Potential application in the synthesis of novel compounds for crop protection and agricultural science.
• Material Science: Investigated for use in the creation of organic electronic materials due to its conjugated heterocyclic system.

Basic Information

Item	Details
Product Name	4-(2-Methyl-Imidazo[1,2-A]Pyrimidin-3-Yl)-Thiazol-2-Ylamine
CAS No.	886507-69-3
Molecular Formula	C10H9N5S
Molecular Weight	231.28 g/mol
Synonyms	4-(2-Methylimidazo[1,2-a]pyrimidin-3-yl)-1,3-thiazol-2-amine; 2-Amino-4-(2-methylimidazo[1,2-a]pyrimidin-3-yl)thiazole; 886507-69-3; 4-(2-Methylimidazo[1,2-a]pyrimidin-3-yl)thiazol-2-amine; 3-(2-Aminothiazol-4-yl)-2-methylimidazo[1,2-a]pyrimidine
EINECS	Contact for details

Quality Control

Our production of 4-(2-Methyl-Imidazo[1,2-A]Pyrimidin-3-Yl)-Thiazol-2-Ylamine adheres to stringent quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC for purity verification and NMR/LC-MS for structural confirmation, to ensure it meets the exacting standards required for pharmaceutical R&D. Certificates of Analysis (COA) with full traceability are provided to guarantee supply reliability and batch-to-batch consistency.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). This compound may be hygroscopic; therefore, containers should be kept sealed to minimize exposure to atmospheric moisture.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.